Sandoz Inc. v. Amgen Inc.

137 S. Ct. 908, 197 L. Ed. 2d 82, 85 U.S.L.W. 3362, 2017 WL 125661, 2017 U.S. LEXIS 908
Procedural entryThis page is a short order in Sandoz Inc. v. Amgen Inc.. Read the opinion of the Court — 582 U.S. 1
Supreme Court of the United States·Decided January 25, 2017·No. No. 15–1039.·Published

Opinion

The following briefing schedule is adopted:

Petitioner in No. 15-1039 will file an opening brief limited to the question presented in its petition, not to exceed 15,000 words, on or before Friday, February 10, 2017. Petitioner in No. 15-1195 will file a consolidated opening brief on the question presented in their petition and response brief, not to exceed 19,000 words, on or before Friday, March 10, 2017. Petitioner in No. 15-1039 will file a consolidated response brief and reply brief, not to exceed 10,000 words, on or before Friday, March 31, 2017. Petitioner in No. 15-1195 will file a reply brief, not to exceed 6,000 words, on or before Friday, April 14, 2017.

Any brief of an amicus curiae in support of petitioner in No. 15-1039 or in support of neither party is to be filed on or before Friday, February 17, 2017, and the brief should bear a light green cover. Any brief of an amicus curiae in support of petitioner in No. 15-1195 is to be filed on or before Friday, March 17, 2017, and the brief should bear a dark green cover. An amicus curiae may file only a single brief in this case.

Free access — add to your briefcase to read the full text and ask questions with AI

Sandoz Inc. v. Amgen Inc., 137 S. Ct. 908, 197 L. Ed. 2d 82, 85 U.S.L.W. 3362, 2017 WL 125661, 2017 U.S. LEXIS 908 (U.S. 2017).

137 S. Ct. 908 (Sandoz Inc. v. Amgen Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.